Literature DB >> 27350446

Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Thomas Welte, Ik Sun Kim, Lin Tian, Xia Gao, Hai Wang, June Li, Xue B Holdman, Jason I Herschkowitz, Adam Pond, Guorui Xie, Sarah Kurley, Tuan Nguyen, Lan Liao, Lacey E Dobrolecki, Lan Pang, Qianxing Mo, Dean P Edwards, Shixia Huang, Li Xin, Jianming Xu, Yi Li, Michael T Lewis, Tian Wang, Thomas F Westbrook, Jeffrey M Rosen, Xiang H-F Zhang.   

Abstract

Entities:  

Year:  2016        PMID： 27350446     DOI： 10.1038/ncb3379

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  1 in total

1.  Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Authors:  Thomas Welte; Ik Sun Kim; Lin Tian; Xia Gao; Hai Wang; June Li; Xue B Holdman; Jason I Herschkowitz; Adam Pond; Guorui Xie; Sarah Kurley; Tuan Nguyen; Lan Liao; Lacey E Dobrolecki; Lan Pang; Qianxing Mo; Dean P Edwards; Shixia Huang; Li Xin; Jianming Xu; Yi Li; Michael T Lewis; Tian Wang; Thomas F Westbrook; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Nat Cell Biol       Date:  2016-05-16       Impact factor: 28.824
  1 in total
  1 in total

Review 1.  Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.

Authors:  Ryuhjin Ahn; Josie Ursini-Siegel
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.